Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage.

K, Matsueda; M, Hongo; J, Tack; H, Aoki; Y, Saito; H, Kato

doi:10.1111/j.1365-2982.2009.01449.x

Public

Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage.

Shared by NobleBlocks on Jan 5, 2010 • 12:00 AM UTC

Authors:

Matsueda K

Hongo M

Tack J

Abstract

<h4>Background</h4>Acotiamide is a selective acetylcholinesterase inhibitor and enhances the actions of cholinergic neurons localized in the stomach.<h4>Methods</h4>The present two studies were conducted to examine the optimal dosage of acotiamide hydrochloride (Z-338) in patients with functional dy...

Discussions